Lv5121
1600 积分 2025-08-21 加入
Exploring the Molecular Features and Clinicopathological Correlations of Diffuse Sclerosing Papillary Thyroid Carcinoma
10天前
已完结
Clinicopathological Features of CCDC6-RET and NCOA4-RET Fusions in Thyroid Cancer: A Single-Center Retrospective Cohort Study in a Chinese Population
10天前
已完结
Preoperative Co-Mutation of BRAF V600E and TERT Promoter Predicts Tumor Aggressiveness and Recurrence-Free Survival in Papillary Thyroid Carcinoma
1个月前
已完结
Radioiodine-refractory differentiated thyroid cancer: Molecular mechanisms and therapeutic strategies for radioiodine resistance
2个月前
已完结
2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer
3个月前
已完结
Medullary Thyroid Cancer Risk and Mortality in Carriers of Incidentally Identified MEN2A RET Variants
3个月前
已完结
Multifocal papillary thyroid carcinoma with RET p.V804M, EML4-ALK fusion, and BRAF V600E positivity
3个月前
已完结
Concomitant BRAF(V600E) mutation and RET/PTC rearrangement is a frequent occurrence in papillary thyroid carcinoma
4个月前
已完结
甲状腺未分化癌诊疗专家共识(2023版)
4个月前
已关闭
皖公网安备34019202002308
